ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
John Butler
Vivek L. Pathi
Geoffrey A. Berg
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butler, J.
Right arrow Articles by Berg, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, J.
Right arrow Articles by Berg, G. A.
Related Collections
Right arrow Extracorporeal circulation

Ann Thorac Surg 2002;74:139-142
© 2002 The Society of Thoracic Surgeons


Original article: cardiovascular

Duroflo II heparin bonding does not attenuate cytokine release or improve pulmonary function

John Butler, FRCS*a, Elijah W. Murithi, FRCSa, Vivek L. Pathi, FRCSa, Kenneth J.D. MacArthur, FRCSa, Geoffrey A. Berg, FRCSa

a Department of Cardiac Surgery, Western Infirmary, Glasgow, Scotland, United Kingdom

Accepted for publication March 11, 2002.

* Address reprint requests to Dr Butler, Department of Cardiac Surgery, Western Infirmary, Dumbarton Rd, Glasgow G14 6NT, Scotland, UK
e-mail: gilmour.wendy.wg{at}northglasgow.scot.nhs.uk

Background. Comparison of the cytokine generation and leukocyte activation properties of Duroflo II heparin bonded bypass circuit (Baxter Healthcare Corp, Compton, UK) and the conventional cardiopulmonary bypass circuit. Attempt to correlate these to pulmonary dysfunction postoperatively.

Methods. Forty patients undergoing elective, isolated coronary artery bypass grafting were randomly allocated to have either plain extracorporeal circuits (group C) or heparin bonded extracorporeal circuits (group H). Full systemic heparinization was used in all patients. The inflammatory response was assessed by measuring plasma levels of interleukin-6, interleukin-8, interleukin-10, and polymorphonuclear elastase. Gas exchange was assessed by measuring the PaO2/FIO2 ratio.

Results. Significant impairment of oxygenation was seen in both groups with the lowest values at the end of the operation before a gradual return to normal during the next 6 hours. There were no differences between the groups in gas exchange or times to extubation. There were significant elevations in all the cytokines, with interleukin-6 levels peaking at 4 hours in group H and 24 hours in group C, before starting to return to normal at 48 hours. The patterns of interleukin-8 and interleukin-10 rise were identical in the two groups. Polymorphonuclear elastase reached a peak at the end of the operation in group H and remained elevated up to 24 hours, whereas levels continued to rise in group C up to 4 hours. There were no significant differences in levels between groups at any time. There were no differences between the groups in blood loss or blood product usage.

Conclusions. Cardiopulmonary bypass induces a systemic inflammatory response with release of cytokines and activation of leukocytes. This correlates with the severe deterioration in pulmonary gas exchange from preoperative levels up to 6 hours postoperatively (p < 0.05). In the presence of systemic heparinization, Duroflo II heparin bonding of the circuits has minor effects on the pattern of evolution of this inflammatory response.




This article has been cited by other articles:


Home page
Card Surg AdultHome page
J. W. Hammon
Extracorporeal Circulation: The Response of Humoral and Cellular Elements of Blood to Extracorporeal Circulation
Card. Surg. Adult, January 1, 2008; 3(2008): 370 - 389.
[Full Text]


Home page
Eur. J. Cardiothorac. Surg.Home page
O. Mangoush, S. Purkayastha, S. Haj-Yahia, J. Kinross, M. Hayward, F. Bartolozzi, A. Darzi, and T. Athanasiou
Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes
Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1058 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. T. Lappegard, M. Fung, G. Bergseth, J. Riesenfeld, and T. E. Mollnes
Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition
Ann. Thorac. Surg., July 1, 2004; 78(1): 38 - 44.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. M. Albes, I. M. Stohr, M. Kaluza, A. Siegemund, D. Schmidt, R. Vollandt, and T. Wahlers
Physiological coagulation can be maintained in extracorporeal circulation by means of shed blood separation and coating
J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1504 - 1512.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. M. Palatianos, C. N. Foroulis, M. I. Vassili, G. Astras, K. Triantafillou, E. Papadakis, A. A. Lidoriki, E. Iliopoulou, and E. N. Melissari
A prospective, double-blind study on the efficacy of the bioline surface-heparinized extracorporeal perfusion circuit
Ann. Thorac. Surg., July 1, 2003; 76(1): 129 - 135.
[Abstract] [Full Text] [PDF]


Home page
PerfusionHome page
T Gourlay and P Connolly
Does cardiopulmonary bypass still represent a good investment? The biomaterials perspective
Perfusion, July 1, 2003; 18(4): 225 - 231.
[Abstract] [PDF]


Home page
Card Surg AdultHome page
P. Menasche and L. H. Edmunds Jr.
Extracorporeal Circulation: The Inflammatory Response
Card. Surg. Adult, January 1, 2003; 2(2003): 349 - 360.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 by The Society of Thoracic Surgeons.